Search

Learn more about from MSK experts about what the latest research on the connection between eating sugar and cancer risk.

… Thursday, April 10, 2025 One of the most misunderstood topics in the complex interplay of food, obesity, and cancer is sugar. The internet is full of misrepresentations and half-truths that lead many people to incorrectly believe that sugar directly causes cancer — or even that cancer can be treated

A protein on certain immune cells is a promising target for making immunotherapy more effective against breast cancer.

… Tuesday, November 29, 2016 Summary Immunotherapy has been less effective against breast cancer than other cancers. Researchers think regulatory T (Treg) cells are restraining the immune system from mounting an adequate attack against breast tumors. New research identifies a protein in specific Treg cells

Discover how Memorial Sloan Kettering’s Multidisciplinary Brain Metastasis Clinic is revolutionizing treatment for metastatic brain tumors.

… Thursday, July 1, 2021 A busy real estate broker and married mother of three, Susan van der Griend is an optimist by nature, used to making things happen and moving on. When she was diagnosed with melanoma in 2017, she decided to be treated near her home in Connecticut. But a positive outlook didn’t

Memorial Sloan Kettering experts are available to comment on new research presented at the American Association for Cancer Research 2016 Annual Meeting including immunotherapy and CAR T cells, exercise oncology, precision medicine and more. For more information and to set up interviews or access photos, email Nicole H. McNamara at [email protected].

… Friday, April 15, 2016 Thousands of oncology experts from around the world will gather in New Orleans from April 16 - 20 for the American Association for Cancer Research 2016 Annual Meeting. This year’s theme, “Delivering Cures Through Cancer Science,” reinforces the inextricable link between research

New data from an international, multicenter Phase III clinical trial has found that the experimental targeted therapy everolimus (RAD001) significantly delays cancer progression in patients with metastatic kidney cancer whose disease had worsened on other treatments.

… Friday, May 16, 2008 New data from an international, multicenter Phase III clinical trial has found that the experimental targeted therapy everolimus (RAD001) significantly delays cancer progression in patients with metastatic kidney cancer whose disease had worsened on other treatments. The study was

Experts from all specialties of breast cancer treatment will attend the 2018 San Antonio Breast Cancer Symposium from December 4 through 8. It is the largest annual meeting devoted solely to the latest in breast cancer advances. The meeting will highlight emerging research and also tackle some of the larger issues facing people with breast cancer and the doctors who treat them.

… Monday, December 3, 2018 Experts from all specialties of breast cancer treatment will attend the 2018 San Antonio Breast Cancer Symposium from December 4 through 8. It is the largest annual meeting devoted solely to the latest in breast cancer advances. The meeting will highlight emerging research and

New MSK research illuminates new details about Thetis cells that will support efforts to harness them therapeutically; shows how the timing and strength of danger signals steer immune cell fates; and employs single-nucleus DNA sequencing to shed new light on the evolution of pancreatic cancer.

… Wednesday, February 4, 2026   New research from Memorial Sloan Kettering Cancer Center (MSK) illuminates new details about Thetis cells that will support efforts to harness them therapeutically; shows how the timing and strength of danger signals steer immune cell fates; and employs single-nucleus DNA

Everolimus plus bevacizumab demonstrates robust activity in treatment-naïve patients with advanced papillary variant nonclear cell renal cell carcinoma.

… Monday, November 9, 2020 Everolimus plus bevacizumab demonstrates robust activity in treatment-naïve patients with advanced papillary variant nonclear cell renal cell carcinoma (nccRCC), according to the results of an expanded single-arm, single-institution phase II trial conducted at Memorial Sloan

Learn how to get enough calories during treatment from MSK specialists in diet and nutrition.

… Tuesday, January 15, 2019 Summary MSK experts offer tips on how people who are currently in cancer treatment can get enough vital calories when they need them most. During cancer treatment, many people face a nutritional double whammy. The disease can rob them of their appetite and sap their strength

BCG has been used to treat bladder cancer for more than 30 years. Scientists are still learning how it works.

… Friday, July 17, 2020 Summary Scientists at Memorial Sloan Kettering have found that BCG, a commonly used immunotherapy for bladder cancer , works differently than many researchers had assumed. For people with early-stage bladder cancer, an immunotherapy called BCG has been the standard treatment for